Cisapride hydrate

Catalog No.S4751 Synonyms: Propulsid, Alimix, Propulsin, Enteropride, Kinestase

For research use only.

Cisapride (Propulsid, Alimix, Propulsin, Enteropride, Kinestase) acts directly as a selective serotonin 5-HT4 receptor agonist with IC50 of 0.483 μM. And It also acts indirectly as a parasympathomimetic.

Cisapride hydrate Chemical Structure

CAS No. 260779-88-2

Selleck's Cisapride hydrate has been cited by 1 Publication

Purity & Quality Control

Choose Selective 5-HT Receptor Inhibitors

Other 5-HT Receptor Products

Biological Activity

Description Cisapride (Propulsid, Alimix, Propulsin, Enteropride, Kinestase) acts directly as a selective serotonin 5-HT4 receptor agonist with IC50 of 0.483 μM. And It also acts indirectly as a parasympathomimetic.
5-HT4 receptor [1]
(Cell-free assay)
hERG [1]
(Cell-free assay)
0.483 μM <1 μM
In vitro

Cisapride inhibits vascular Kv current independently of serotonin 5-HT4-receptor activation[2]. As HERG channel blocker, cisapride, can inhibit the growth of gastric cancer cells by altering distribution of cell cycle and inducing apoptosis so as to be of potential value in the treatment of gastric cancer. Cisapride could inhibit the growth and clonogenicity of human gastric cancer lines by specific blockage of HERG channel in a time- and dose-dependent manner while has little effects on GES cells[3].

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
MCF7 cells MWHGeY5kfGmxbjDhd5NigQ>? NXu4dlNzUW6qaXLpeIlwdiCxZjDoeY1idiCHUlegbY4hVUOINzDj[YxteyxiSVO1NF0xNjByNkS2JO69VQ>? NFzxS3MyQTFzMEO0NS=>
HEK293 cells NVX2TIpHTnWwY4Tpc44h[XO|YYm= MnvMTY5pcWKrdHnvckBw\iCqdX3hckBGWkdidHTbe5Q7TjZ3NlHdJI12fGGwdDDlfJBz\XO|ZXSgbY4hUEWNMkmzJINmdGy|IHL5JJdpd2ynIHPlcIwheGG2Y3igZ4xidXBibXX0bI9lNCCLQ{WwQVAvODFizszN MYGxPVI3ODd|NB?=
CHO cells M3zIfGZ2dmO2aX;uJIF{e2G7 NHj2UlBKdmirYnn0bY9vKG:oIHj1cYFvKEWURzDlfJBz\XO|ZXSgbY4hS0iRIHPlcIx{KGK7IIfoc4xmKGOnbHygdIF1[2hiY3zhcZAhfGWlaH7pdZVmNCCLQ{WwQVAvODN7OEGg{txO NYTDWlY5OTh2NEizOFI>
In vivo Cisapride is widely prescribed for the treatment of gastrointestinal motility dysfunctions, such as gastroesophageal reflux disorder (GERD), chronic intestinal pseudo-obstruction, and slow-transit constipation gastroparesis. Although cisapride is a beneficial prokinetic agent, several common side effects, such as abdominal pain, nausea, diarrhea, and increased frequency of urination, have been reported[2]. In rat, the PK profile indicate the T1/2 for cisapride is 1.48 h[1].

Protocol (from reference)

Cell Research:[3]
  • Cell lines: The human gastric cancer SGC7901, AGS, MGC803 and MKN45 cell lines and human immortalized gastric epithelial GES cell line
  • Concentrations: 0, 12.5, 25, 50, 100 or 200 nM
  • Incubation Time: 1, 3, 5 and 7 day
  • Method: Cells in the logarithmic growth phase are harvested and seeded in 96-well plates. The cell number is diluted to 5000/well in 200 microliters of RPMI1640 medium. In vitro experiments are carried out on the gastric cancer cell lines and GES cell line, using an MTT proliferation assay. MTT stains live cells, and the optical density absorbance at 490nm wavelength correlates with the cell number. Cisapride is added to the cells at concentrations of 0, 12.5, 25, 50, 100 or 200 nM and equivalent volume of ethanol is added as control in order to eliminate the effects of solvent. Twenty microliters of MTT is added to each well of the cell culture 4 h before termination of the culture at 37˚C. One hundred and fifty microliters of dimethyl sulfoxide is added to each well at the end of the culture and the plate is agitated for 10 minutes. The absorbency at 490 nm is read by a BIOHIT BP800 plate reader. Growth curve is drawn according to MTT colorimetry. The inhibition rate is calculated.
Animal Research:[1]
  • Animal Models: Male Sprague-Dawley rats
  • Dosages: 5 mg/kg
  • Administration: i.v.

Solubility (25°C)

In vitro

DMSO 96 mg/mL
(198.36 mM)
Water Insoluble
Ethanol Insoluble

Chemical Information

Molecular Weight 483.96


CAS No. 260779-88-2
Storage 3 years -20°C powder
2 years -80°C in solvent

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Cisapride hydrate | Cisapride hydrate supplier | purchase Cisapride hydrate | Cisapride hydrate cost | Cisapride hydrate manufacturer | order Cisapride hydrate | Cisapride hydrate distributor